101
Participants
Start Date
November 16, 2020
Primary Completion Date
August 31, 2022
Study Completion Date
August 31, 2022
blood collection
Blood samples will be collected as per protocol defined schedule. There is no investigation drug in this study.
Cliniques Universitaires Saint-Luc, Brussels
Algemeen Ziekenhuis Delta - Campus Rumbeke, Roeselare
Ospedale Regina Margherita, Torino
Hôpital Côte De Nacre, Caen
Instituto Giannina Gaslini, Genova
Ospedale San Raffaele, Milan
Centre Hospitalier Régional et Universitaire de Besançon - Hôpital Jean-Minjoz, Besançon
Fondazione IRCCS Policlinico San Matteo, Pavia
Hôpital Haut-Lévêque, Pessac
Hôpital Arnaud de Villeneuve, Montpellier
Hôpital Saint-Eloi, Montpellier Cedex 5
Hôpital Pontchaillou, Rennes
Centre Hospitalier Universitaire Grenoble Alpes, La Tronche
Centre Hosptitalier Universitaire d'Angers, Angers
Hôpitaux de Brabois, Vandœuvre-lès-Nancy
Centre Hospitalier Universitaire Estaing, Clermont-Ferrand
Hôpital Saint-Louis, Paris
Hôpital Universitaire Robert-Debré, Paris
Azienda Ospedaliera San Giuseppe Moscati, Avellino
Universitätsklinikum Tübingen, Tübingen
Ospedale Pediatrico Bambino Gesù - Roma - Gianicolo, Roma
Prinses Maxima Centrum Kinderoncologie, Utrecht
Cardiff and Vale University Health Board, Cardiff
The Royal Marsden Hospital - London, London
Imperial College Healthcare NHS Trust NHS Trust, London
Lead Sponsor
Collaborators (2)
PRA Health Sciences
INDUSTRY
Cytel Inc.
INDUSTRY
BioMérieux
INDUSTRY
Swedish Orphan Biovitrum
INDUSTRY